Genetic aspects of HPV infection detection in tumor and adjacent tissues of patients with laryngeal squamous cell carcinoma

Cover Page


Cite item

Full Text

Abstract

The article describes methods for the human papillomavirus (HPV) detection in tumor and adjacent (morphologically intact) tissues of patients with laryngeal squamous cell carcinoma (LSSC) in terms of viral pathogenesis. Comparative evaluation of the principles and techniques for HPV detection was performed. Advantages and disadvantages of the HPV detection methods are described. Approaches for DNA and HPV oncoproteins E6-E7 identification are substantiated. The results of our research into the qualitative and quantitative detection of HPV in the tumor and adjacent tissues of patients with Lssc are described. The research was conducted using commercial test systems Amplisens HPV HR screen-titre-FL and Amplisens HPV HR genotype-FL. Based on these results we developed the algorithm of HPV detection in samples of tumor tissue of patients with Lssc. The need for typing HPV-positive tissue samples with low concentration of HPV DNA was discussed.

About the authors

O. Yu. Dvoryaninova

Tomsk Cancer Research Institute

Author for correspondence.
Email: noemail@neicon.ru
Россия

E. G. Nikitina

Tomsk Cancer Research Institute; National Research Tomsk State University

Email: noemail@neicon.ru
Россия

V. A. Bychkov

Tomsk Cancer Research Institute

Email: va.bych@gmail.com
Россия

N. V. Litviakov

Tomsk Cancer Research Institute; National Research Tomsk State University

Email: noemail@neicon.ru
Россия

References

  1. Куевда Д.А., Шипулина О.Ю. Количественный подход в диагностике папилломавирусной инфекции. Практическая онкология. 2006; 7(3): 135-41.
  2. Meijer C.J., Snijers P.J., Castle P.E. Clinical utility of HPV genotyping. Gynecol. Oncol. 2006; 103 (1): 12-7.
  3. Hafner N., Driesch C., Gajda M., Jansen L., Kirchmayr R., Runnebaum I.B. et al. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene. 2008; 27: 1610-7.
  4. Van Tine B.A., Kappes J.C., Banerjee N.S., Knops J., Lai L., Syeenbergen R.D. et al. Clonal selection for transcriptionally active oncogenes during progression to cancer. J. Virol. 2004; 78(20): 11172-86.
  5. Briolat J., Dalstein V., Saunier M., Joseph K., Caudroy S., Pre J.L. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int. J. Cancer. 2007; 121: 2198-204.
  6. Zheng Z.M., Baker C.C. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front. Biosci. 2006; 11: 2286-302.
  7. Olthof N.C., Huebbers C.U., Kolligs J., Henfling M., Ramaekers F.C., Cornet I. et al. Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines. Int. J. Cancer. 2015; 136(5): 207-18.
  8. Jung A.C., Briolat J., Millon R., de Reyniès A., Rickman D., Thomas E. et al. Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int. J. Cancer. 2010; 126(8): 1882-94.
  9. De Marco L., Gillio-Tos A., Bonello L., Ghisetti V., Ronco G., Merletti F. Detection of human papillomavirus type 16 integration in pre-neoplastic cervical lesions and confirmation by DIPS-PCR and sequencing. J. Clin. Virol. 2007; 38(1): 7-13.
  10. Peitsaro P., Johanson B., Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J. Clin. Microbiol. 2002; 40(3): 886-91.
  11. Klaes R., Woerner S.M., Ridder R., Wentzensen N., Duerst M., Schneider A. et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 1999; 59(24): 6132-6.
  12. Mellin H., Dahlgren L., Munck-Wikland E., Lindholm J., Rabbani H., Kalantari M. et al. Human/papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int. J. Cancer. 2002; 102(2): 152-8.
  13. Wiest T., Schwarz E., Enders C., Flechtenmacher C., Bosch F.X. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene. 2002; 21: 1510-7.
  14. Bechtold V., Beard P., Raj K. Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA.J. Virol. 2003; 77: 2021-8.
  15. Ragin C.C., Reshmi S.C., Gullin S.M. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int. J. Cancer. 2004; 110: 701-9.
  16. Zaravinos A., Mammas I.N., Sourvinos G., Spandidos D.A. Molecular detection methods of human papillomavirus (HPV). Int. J. Biol. Markers. 2009; 24(4): 215-22.
  17. Sehr P., Muller M., Höpfl R., Widschwendter A., Pawlita M. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J. Virol. Methods. 2002; 106(1): 61-70.
  18. Wentzensen N., Vinokurova S., von Knebel Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 2004; 64(11): 3878-84.
  19. Molden T., Kraus I., Karlsen F., Skomedal H., Nygård J.F., Hagmar B. Comparison of Human Papillomavirus messenger RNA an DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2 year follow-up of high-grade squamous intraepithelial lesion. Cancer Epidemiol. Biomarkers Prev. 2005; 14(2): 367-72.
  20. Chaiwongkot A., Pientong C., Ekalaksananan T., Vinokurova S., Kongyingyoes B., Chumworathayi B. et al. Detection of the human papillomavirus 58 physical state using the amplification of papillomavirus oncogene transcripts assay. J. Virol. Methods. 2013; 189(2): 290-8.
  21. Hill C.S. Molecular diagnostic testing for infectious diseases using TMA technology. Expert Rev. Mul. Diagn. 2001; 1(4): 445-55.
  22. Bogusiak K., Kobos J. The role of human papillomavirus infection in the head and neck region and methods for its detection. Pol. J. Pathol. 2014; 65(1): 1-14.
  23. Iftner T., Villa L.L. Human papillomavirus technologies. J. Natl. Cancer Inst. Monogr. 2003; (31): 80-8.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Dvoryaninova O.Y., Nikitina E.G., Bychkov V.A., Litviakov N.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-77676 от 29.01.2020.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies